Dynavax Technologies
DVAX
A$15.88
Share price
3.10%
Change (1 day)
-6.77%
Change (1 year)
Categories
Dynavax Technologies (DVAX) - Total debt
Total debt on the balance sheet as of March 2025 : A$0.44 Billion
According to Dynavax Technologies 's latest financial reports the company's total debt is A$0.44 Billion. A company’s total debt is the sum of all current and non-current debts.
Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | A$0.40 B | 8.47% |
| 2023-12-31 | A$0.37 B | -0.54% |
| 2022-12-31 | A$0.37 B | 6.8% |
| 2021-12-31 | A$0.35 B | 25.31% |
| 2020-12-31 | A$0.28 B | -8.36% |
| 2019-12-31 | A$0.30 B | 115.91% |
| 2018-12-31 | A$0.14 B | |
| 2014-12-31 | A$11.68 M | |
| 2012-12-31 | N/A | -100% |
| 2011-12-31 | A$12.49 M | 7.71% |
| 2010-12-31 | A$11.59 M | -15.85% |
| 2009-12-31 | A$13.78 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Agenus
AGEN | A$0.14 B | -67.82% | 🇺🇸 USA |
 Biogen BIIB | A$10.20 B | 2,214.88% | 🇺🇸 USA |
 Merck MRK | A$53.72 B | 12,082.02% | 🇺🇸 USA |
 Gilead Sciences GILD | A$38.47 B | 8,623.62% | 🇺🇸 USA |
 AstraZeneca AZN | A$48.25 B | 10,840.89% | 🇬🇧 UK |
 GlaxoSmithKline GSK | A$36.77 B | 8,237.58% | 🇬🇧 UK |
 Pfizer PFE | A$94.50 B | 21,328.32% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | A$26.11 B | 5,822.15% | 🇮🇱 Israel |
 Amgen AMGN | A$88.47 B | 19,961.32% | 🇺🇸 USA |